http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-272864-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-04
filingDate 1927-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1928-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-272864-A
abstract 272,864. Commercial Solvents Corporation, (Assignees of Woodruff, J. C., and Bloomfield, G.). June 21, 1926, [Convention date]. Methanol.-For the synthesis of methanol by the catalytic interaction of carbon oxides and hydrogen at elevated temperature and pressure, catalysts are employed which comprise a mixture of metal oxides non-reducible under the conditions of the synthesis to which a metallic halide is added. Preferably the non-reducible oxides are those, of metals of the second periodic group to which an oxide of a metal of the third to seventh groups is added as a promoter, whilst the amount of halide used is less than one chemical equivalent of the amount of the principal oxide present. Catalyst mixtures specified are zinc oxide-chromium oxide-zinc chloride or vanadium chloride, zinc oxide-manganese oxide or vanadium oxide-magnesium chloride, magnesium oxide - vanadium oxide - magnesium fluoride, magnesium oxide-chromium oxidechromium chloride, strontium oxide-chromium oxide-zinc chloride. Examples of the preparation of the catalysts are given, and in the case of each catalyst, the yield of methanol under specified reaction conditions is stated. Specification 227, 147 is referred to. The Specification, as open to inspection under Sect. 91 (3 (a), refers to the use of a catalyst comprising a single non-reducible metal oxide and a metallic halide. This subject-matter does not appear in the Specification as accepted,
priorityDate 1926-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157634060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450699202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449460707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22002748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450828377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452177314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452860309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450792925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160505160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448219734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159550943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159525524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159458060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427267

Total number of triples: 30.